The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy SHANGHAI, Nov. 6, 2025 /PRNewswire/ -- On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics...

AMTD Digital subsidiary TGE's Hotels Portfolio Anticipated to Exceed 1,000 Rooms and double its Revenue

AMTD Digital subsidiary TGE's Hotels Portfolio Anticipated to Exceed 1,000 Rooms and double its Revenue

PARIS and NEW YORK and SINGAPORE, Nov. 3, 2025 /PRNewswire/ -- AMTD Group Inc. ("AMTD" or the "Group"), AMTD IDEA Group ("AMTD IDEA Group") (NYSE: AMTD; SGX: HKB) and The Generation Essentials Group ("TGE", NYSE: TGE), a subsidiary of AMTD Digital...

Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection

Ribo Granted EMA Orphan Drug Designation for siRNA Therapeutic RBD1016 for Hepatitis Delta Virus (HDV) Infection

BEIJING and GOTHENBURG, Sweden, Oct. 24, 2025 /PRNewswire/ -- Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo), today announced that the European Medicines Agency (EMA) has granted Orphan Drug Designation (ODD) to RBD1016...

SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

SABRE topline results: Cu-64 SAR-Bombesin is effective in detecting prostate cancer recurrence in patients with negative SOC imaging

Highlights Topline data from Clarity's diagnostic Phase II trial, SABRE, showed that 64Cu-SAR-Bombesin was safe, well tolerated and effective at detecting prostate cancer in patients with biochemical recurrence (BCR) who are negative or equivocal on...

Kepler K2 "Bumblebee" Debuts at ICRA 2025, Captivating Attendees

Kepler K2 "Bumblebee" Debuts at ICRA 2025, Captivating Attendees

ATLANTA, June 3, 2025 /PRNewswire/ -- During the IEEE International Conference on Robotics and Automation 2025 (ICRA 2025) held in Atlanta from May 19 to 23, Shanghai Kepler Robotics Co., Ltd ("Kepler Humanoid Robot") introduced its latest...

Datasea Announces Entry into Agreements that Will Place its Acoustic High-Tech Products in a Total of 263 Beauty Stores in Northern China

Datasea Announces Entry into Agreements that Will Place its Acoustic High-Tech Products in a Total of 263 Beauty Stores in Northern China

The New Agreements Projected to Generate Sales of up to 140,000 Units and $11 Million in Revenue by Year End 2025 BEIJING, Jan. 6, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS, "Datasea" or "the Company"), a Nevada-based digital technology...

menu
menu